Cysteinyl leukotriene receptors, old and new; implications for asthma
暂无分享,去创建一个
[1] N. Bhattacharyya,et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. , 2012, Blood.
[2] K. Austen,et al. Dectin-2 mediates Th2 immunity through the generation of cysteinyl leukotrienes , 2011, The Journal of experimental medicine.
[3] K. Austen,et al. GPR17 Regulates Immune Pulmonary Inflammation Induced by House Dust Mites , 2010, The Journal of Immunology.
[4] A. Sjölander,et al. Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer. , 2010, European journal of cancer.
[5] S. Paruchuri,et al. Leukotriene E4–induced pulmonary inflammation is mediated by the P2Y12 receptor , 2009, The Journal of experimental medicine.
[6] K. Austen,et al. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4 , 2009, Proceedings of the National Academy of Sciences.
[7] K. Austen,et al. Dectin-2 Recognition of House Dust Mite Triggers Cysteinyl Leukotriene Generation by Dendritic Cells1 , 2009, The Journal of Immunology.
[8] B. Bacskai,et al. P2Y6 Receptors Require an Intact Cysteinyl Leukotriene Synthetic and Signaling System to Induce Survival and Activation of Mast Cells1 , 2009, The Journal of Immunology.
[9] K. Austen,et al. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors , 2008, Proceedings of the National Academy of Sciences.
[10] J. Plutzky,et al. Leukotriene E4 Activates Peroxisome Proliferator-activated Receptor γ and Induces Prostaglandin D2 Generation by Human Mast Cells* , 2008, Journal of Biological Chemistry.
[11] J. Mallol,et al. Basic Concepts in G-Protein-Coupled Receptor Homo- and Heterodimerization , 2007, TheScientificWorldJournal.
[12] B. Bacskai,et al. CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. , 2007, Blood.
[13] K. Siminovitch,et al. A functional G300S variant of the cysteinyl leukotriene 1 receptor is associated with atopy in a Tristan da Cunha isolate , 2007, Pharmacogenetics and genomics.
[14] N. Acevedo,et al. The A-444C polymorphism of leukotriene C4 synthase gene is associated with IgE antibodies to Dermatophagoides pteronyssinus in a Colombian population. , 2007, The Journal of allergy and clinical immunology.
[15] M. Trincavelli,et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptor , 2006, The EMBO journal.
[16] Yongfeng Jiang,et al. Cutting Edge: Interleukin 4-Dependent Mast Cell Proliferation Requires Autocrine/Intracrine Cysteinyl Leukotriene-Induced Signaling1 , 2006, The Journal of Immunology.
[17] Pascual Ferrara,et al. The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[18] K. Jacobson,et al. CysLT1 leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors. , 2005, Biochemical pharmacology.
[19] M. Accomazzo,et al. CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation , 2005, Journal of Cell Science.
[20] N. Fujita,et al. Identification of endogenous surrogate ligands for human P2Y12 receptors by in silico and in vitro methods. , 2005, Biochemical and biophysical research communications.
[21] Eleuza R Machado,et al. Leukotrienes Play a Role in the Control of Parasite Burden in Murine Strongyloidiasis1 , 2005, The Journal of Immunology.
[22] H. Shin,et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics , 2005, Pharmacogenetics and genomics.
[23] J. Holloway,et al. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid‐intolerant asthma , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[24] Zeba M. Khan,et al. Leukotrienes and atherosclerosis. , 2005, Indian heart journal.
[25] Y. Kanaoka,et al. Cysteinyl Leukotrienes and Their Receptors: Cellular Distribution and Function in Immune and Inflammatory Responses1 , 2004, The Journal of Immunology.
[26] D. Friend,et al. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] Jilly F. Evans,et al. A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da Cunha. , 2003, Pharmacogenetics.
[28] K. Austen,et al. Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] E. Israel,et al. Effects of montelukast and beclomethasone on airway function and asthma control. , 2002, The Journal of allergy and clinical immunology.
[30] C. Funk,et al. Cysteinyl leukotriene receptors. , 2002, Biochemical pharmacology.
[31] R. Simon,et al. The effect of leukotriene‐modifier drugs on aspirin‐induced asthma and rhinitis reactions , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[32] K. Austen,et al. Cysteinyl Leukotrienes and Uridine Diphosphate Induce Cytokine Generation by Human Mast Cells Through an Interleukin 4–regulated Pathway that Is Inhibited by Leukotriene Receptor Antagonists , 2002, The Journal of experimental medicine.
[33] N. Copeland,et al. The Murine Cysteinyl Leukotriene 2 (CysLT2) Receptor , 2001, Journal of Biological Chemistry.
[34] P. O'Byrne,et al. Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma. , 2001, American journal of respiratory and critical care medicine.
[35] K. Austen,et al. Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[36] C. Hougaard,et al. Identification of a murine cysteinyl leukotriene receptor by expression in Xenopus laevis oocytes. , 2001, Biochimica et biophysica acta.
[37] Jilly F. Evans,et al. Characterization of the Human Cysteinyl Leukotriene 2 Receptor* , 2000, The Journal of Biological Chemistry.
[38] Jilly F. Evans,et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor , 1999, Nature.
[39] Lynn Wei,et al. Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma , 1999, Annals of Internal Medicine.
[40] J. Bernstein,et al. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. , 1999, JAMA.
[41] M. Lieberman,et al. γ-Glutamyl Leukotrienase, a γ-Glutamyl Transpeptidase Gene Family Member, Is Expressed Primarily in Spleen* , 1998, The Journal of Biological Chemistry.
[42] J. Bernstein,et al. Montelukast for Chronic Asthma in 6- to 14-Year-Old Children A Randomized, Double-blind Trial , 1998 .
[43] L. Dubé,et al. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial , 1996 .
[44] E. Israel,et al. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. Zileuton Clinical Trial Group. , 1996, JAMA.
[45] G. Freeman,et al. Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Maclouf,et al. Leukotriene C4 Formation by Transcellular Biosynthesis a , 1994, Annals of the New York Academy of Sciences.
[47] B. Spur,et al. Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects. , 1993, The European respiratory journal.
[48] R. Malaviya,et al. Reversible translocation of 5-lipoxygenase in mast cells upon IgE/antigen stimulation. , 1993, The Journal of biological chemistry.
[49] B. Spur,et al. Effect of indomethacin on leukotriene4-induced histamine hyperresponsiveness in asthmatic subjects. , 1992, The American review of respiratory disease.
[50] E. Israel,et al. Recovery of leukotriene E4 from the urine of patients with airway obstruction. , 1992, The American review of respiratory disease.
[51] B. Spur,et al. The mechanism of LTE4‐induced histamine hyperresponsiveness in guinea‐pig tracheal and human bronchial smooth muscle, in vitro , 1991, British journal of pharmacology.
[52] A. Ford-hutchinson,et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. , 1991, The American review of respiratory disease.
[53] W. Owen,et al. The identification of a distinct export step following the biosynthesis of leukotriene C4 by human eosinophils. , 1989, The Journal of biological chemistry.
[54] J. Arm,et al. Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma. , 1989, The American review of respiratory disease.
[55] J. Drazen,et al. Pulmonary responses to bronchoconstrictor agonists in the mouse. , 1988, Journal of applied physiology.
[56] E. R. Mcfadden,et al. Bronchoconstrictor effects of leukotriene E4 in normal and asthmatic subjects. , 1987, The American review of respiratory disease.
[57] J. Drazen. Inhalation challenge with sulfidopeptide leukotrienes in human subjects. , 1986, Chest.
[58] E. Corey,et al. Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[59] E. R. Mcfadden,et al. Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. , 1983, JAMA.
[60] E. R. Mcfadden,et al. Effects of leukotriene D on the airways in asthma. , 1983, The New England journal of medicine.
[61] K. Frank Austen,et al. Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin , 1983 .
[62] Robert A. Lewis,et al. Bronchoconstrictor effects of leukotriene C in humans. , 1982, Science.
[63] E. Corey,et al. Effects of leukotriene E on pulmonary mechanics in the guinea pig. , 1982, The American review of respiratory disease.
[64] B. Spur,et al. The mechanism of LTE 4 '-induced histamine hyperresponsiveness in guinea-pig tracheal and human bronchial smooth muscle , in vitro , 2006 .
[65] E. Silverman,et al. Heterogeneity of therapeutic responses in asthma. , 2000, British medical bulletin.
[66] M. Lieberman,et al. gamma-glutamyl leukotrienase, a gamma-glutamyl transpeptidase gene family member, is expressed primarily in spleen. , 1998, The Journal of biological chemistry.
[67] L. Dubé,et al. Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group. , 1996, The Journal of allergy and clinical immunology.
[68] E. Corey,et al. Conversion of leukotriene D4 to leukotriene E4 by a dipeptidase released from the specific granule of human polymorphonuclear leucocytes. , 1983, Immunology.
[69] E. Corey,et al. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. , 1983, The Journal of investigative dermatology.
[70] E. R. Mcfadden,et al. Comparative bronchoconstrictor effects of histamine, leukotriene C, and leukotriene D in normal human volunteers. , 1982, Transactions of the Association of American Physicians.